Document is current
Any future updates will be listed below
-
Authors
Griffin, Gabriel K.
Wu, Jingyi
Iracheta-Vellve, Arvin https://orcid.org/0000-0002-6635-3904
Patti, James C. https://orcid.org/0000-0002-1733-6702
Hsu, Jeffrey https://orcid.org/0000-0001-6065-4653
Davis, Thomas
Dele-Oni, Deborah
Du, Peter P. https://orcid.org/0000-0003-2652-0541
Halawi, Aya G.
Ishizuka, Jeffrey J.
Kim, Sarah Y.
Klaeger, Susan https://orcid.org/0000-0002-0074-5163
Knudsen, Nelson H. https://orcid.org/0000-0002-0384-1097
Miller, Brian C. https://orcid.org/0000-0001-5931-4184
Nguyen, Tung H.
Olander, Kira E.
Papanastasiou, Malvina https://orcid.org/0000-0003-3378-6612
Rachimi, Suzanna
Robitschek, Emily J.
Schneider, Emily M. https://orcid.org/0000-0001-5778-9119
Yeary, Mitchell D.
Zimmer, Margaret D.
Jaffe, Jacob D. https://orcid.org/0000-0001-9845-1210
Carr, Steven A.
Doench, John G. https://orcid.org/0000-0002-3707-9889
Haining, W. Nicholas
Yates, Kathleen B.
Manguso, Robert T. https://orcid.org/0000-0003-1336-413X
Bernstein, Bradley E. https://orcid.org/0000-0002-5726-6278
- License Information
-
More Information
Article History
Received: 14 August 2020
Accepted: 7 April 2021
First Online: 5 May 2021
Competing interests
: G.K.G. consults for Moderna Therapeutics. J.J.I. consults for Tango Therapeutics and Phenomic AI. B.C.M. consults for Rheos Medicines. J.G.D. consults for Agios, Foghorn Therapeutics, Maze Therapeutics, Merck and Pfizer; J.G.D. consults for and has equity in Tango Therapeutics. S.C.A. is a member of the scientific advisory boards of Kymera, PTM BioLabs and Seer and an ad hoc scientific advisor to Pfizer and Biogen. R.T.M. consults for Bristol Myers Squibb. B.E.B. declares outside interests in Fulcrum Therapeutics, Arsenal Biosciences, HiFiBio, Cell Signaling Technologies and Chroma Medicine. The remaining authors declare no competing interests.
